CorrespondenceLobectomy versus limited resection in T1 N0 lung cancer
Reference (1)
Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer
Ann Thorac Surg
(1995)
Cited by (55)
So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer
2024, Clinical Lung CancerClinical Significance of Regional Lymph Node Evaluation During Sublobar Resection in Lung Cancer
2022, Annals of Thoracic SurgeryEarly-stage lung cancer: Is there still a role for surgery?
2020, Revue des Maladies RespiratoiresSurvival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less
2019, Annals of Thoracic SurgerySublobar Resection: Ongoing Controversy for Treatment for Stage I Non–Small Cell Lung Cancer
2016, Thoracic Surgery ClinicsCitation Excerpt :It was designed to prove that sublobar resections would not be inferior to lobectomies with regard to local recurrence and cancer-free survival, but reported a 3-fold increase in local recurrence and a nonsignificant decrease in overall survival following sublobar resection. Despite the fact that a subsequent analysis decreased the significance of these differences,2 this study standardized lobectomy as the treatment of choice for stage IA NSCLC and has guided surgical care for the past 20 years. There is a slow recognition that the findings from the landmark trial may now belong to a different era.
Imaging the Post-Thoracotomy Patient. Anatomic Changes and Postoperative Complications.
2014, Radiologic Clinics of North America
Copyright © 1996 Published by Elsevier Inc.